Particle.news

Download on the App Store

Kenvue Rebounds as White House Stops Short of Tylenol Ban After Trump Autism Claim

Regulators cite inconclusive evidence, choosing label updates plus a nationwide PSA.

Overview

  • President Trump urged people, including pregnant women, not to take Tylenol while asserting a link to autism without presenting new evidence.
  • The administration said current research does not definitively establish causality between acetaminophen use in pregnancy and autism.
  • HHS confirmed plans to pursue updated warning labels and launch a nationwide campaign advising the lowest effective dose for the shortest duration during pregnancy.
  • Kenvue shares, down more than 7% on Monday, recovered about 60% of their recent losses by midday Tuesday as investors reassessed the lack of a ban.
  • ACOG said recent studies show no significant association between prenatal acetaminophen use and autism and warned that untreated fever in pregnancy carries risks; Kenvue urged expecting mothers to consult clinicians and continues a strategic review with Centerview under activist pressure.